Company / Operating Margin
Eloxx Pharmaceuticals, Inc. Operating Margin History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-5019.9%
FY2016
5-year range
-69210.0% / -5019.9%
FY2014-FY2016
Trend
+91.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -69210.0% to -5019.9% over the past 2 years.
Based on SEC 10-K filings.
-5019.9% in FY2016.
Improved from -69210.0% to -5019.9% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, operating margin increased 91.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2016 | -5019.9% | +91.6% |
| FY2015 | -59476.9% | +14.1% |
| FY2014 | -69210.0% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026